method
review
case
record
patient
admit
persahabatan
hospit
rsp
jakarta
indonesia
infl
uenza
confi
rmed
realtim
polymeras
chain
reaction
result
twentytwo
previous
well
patient
age
year
median
year
identifi
ed
attend
clinic
hospit
median
day
ill
rang
time
fi
rst
dose
oseltamivir
three
die
receiv
oseltamivir
day
median
day
administ
mostli
n
rsp
nineteen
patient
requir
mechan
ventil
death
number
case
fatal
occur
within
hour
day
rsp
admiss
correspond
day
ill
admiss
hyperglycemia
mgdl
unrel
steroid
known
underli
diabet
mellitu
elev
ddimer
level
mgl
upper
limit
normal
mgl
present
patient
respect
fibrinogen
concentr
mostli
lownorm
mgdl
median
normal
mgdl
wherea
creactiv
protein
ferritin
level
increas
risk
factor
death
univari
analysi
includ
increas
ddimer
hyperglycema
increas
urea
extens
chest
radiograph
shadow
lower
admiss
oxygen
satur
conclus
earli
diagnosi
effect
treatment
human
infl
uenza
infect
remain
challeng
patient
refer
late
advanc
diseas
oseltamivir
limit
clinic
impact
elev
ddimer
level
consist
fi
brinolysi
hyperglycemia
warrant
research
determin
underli
mechan
optim
treatment
abbrevi
ali
acut
lung
injuri
aptt
activ
partial
thromboplastin
time
cxr
chest
radiograph
dic
dissemin
intravascular
coagul
isth
intern
societi
thrombosi
hemostasi
ivig
iv
human
ig
ldh
lactat
dehydrogenas
pcr
polymeras
chain
reaction
pt
prothrombin
time
rt
revers
transcriptas
sofa
sepsi
organrel
failur
assess
uln
upper
limit
normal
n
indonesia
saw
fi
rst
patient
highli
pathogen
avian
infl
uenza
total
confi
rmed
infl
uenza
case
number
account
onethird
global
total
circul
clade
indonesia
gener
sensit
vitro
oseltamivir
carboxyl
intrins
less
sensit
clade
virus
mostli
adamantin
resist
oseltamivir
treatment
current
avail
indonesia
human
infl
uenza
mortal
rate
high
indonesia
around
independ
prognost
factor
mortal
indonesian
patient
confi
rmed
infl
uenza
poverti
delay
oseltamivir
treatment
cluster
cluster
infect
typic
prompt
screen
suspect
earlier
treatment
smaller
clinic
seri
also
identifi
ed
late
present
suggest
mani
poor
prognost
featur
leukopenia
absolut
lymphopenia
l
neutropenia
thrombocytopenia
elev
plasma
lactat
dehydrogenas
ldh
corticosteroid
use
osel
tamivir
antivir
treatment
bilater
report
summar
clinic
laboratori
fi
nding
manag
infl
uenza
infect
patient
hospit
jakarta
indonesia
experi
similar
report
other
describ
new
fi
nding
may
bear
upon
clinic
manag
identifi
specifi
c
area
need
detail
investig
patient
admit
respiratori
unit
persahabatan
hospit
referr
center
diagnosi
treatment
human
avian
infl
uenza
patient
suspect
infl
uenza
infect
throat
nasal
swab
primari
diagnost
respiratori
sampl
analysi
realtim
revers
transcriptas
rt
pcr
perform
world
health
organizationapprov
refer
laboratori
nation
institut
health
research
develop
jakarta
laboratori
lack
biosafeti
level
facil
viral
cultur
rectal
swab
endotrach
aspir
pleural
fl
uid
also
obtain
small
number
patient
part
care
patient
report
rtpcrposit
infl
uenza
throat
swab
patient
manag
intens
isol
ward
equip
ventil
data
extract
retrospect
patient
medic
note
use
standard
defi
nition
acut
lung
injuri
ali
ard
ie
pa
f
io
ratio
respect
bilater
cxr
infi
ltrate
evid
left
atrial
hypertens
lungprotect
ventil
use
ventil
patient
consist
ard
network
guidelin
presumpt
evid
consumpt
coagulopathi
defi
ned
increas
greater
upper
limit
normal
uln
ddimer
level
prothrombin
pt
activ
partial
thromboplastin
time
aptt
platelet
count
l
dissemin
intravascular
coagul
dic
determin
use
intern
societi
thrombosi
hemostasi
isth
score
platelet
count
pt
fi
brinogen
fi
brinogen
degrad
score
overt
dic
nonovert
dic
pleural
fl
uid
defi
ned
exud
ldh
concentr
uln
serum
ldh
uln
iul
pleural
fl
uidtoplasma
ratio
total
protein
ldh
sepsi
organrel
failur
assess
sofa
use
assess
admiss
ill
sever
higher
score
indic
greater
sever
sofa
score
per
organ
system
respiratori
pa
f
io
ratio
liver
total
bilirubin
renal
creatinin
function
level
conscious
glasgow
coma
score
mean
arteri
bp
coagul
platelet
count
ethic
approv
consid
necessari
retrospect
studi
patient
seen
januari
may
suspect
infl
uenza
infect
confi
rmed
rtpcr
examin
throat
swab
tabl
posit
sampl
infl
uenza
rectal
swab
n
endotrach
aspir
n
bronchial
wash
n
pleural
fl
uid
n
eighteen
patient
famili
member
gave
histori
contact
chicken
patient
shadow
chest
radiograph
cxr
ard
viremia
high
viral
load
respiratori
sampl
high
plasma
cytokin
concentr
main
clinic
featur
infl
uenza
well
describ
bias
knowledg
deriv
almost
entir
sever
ill
hospit
patient
mild
diseas
asymptomat
seroconvers
report
expos
famili
member
healthcar
worker
rare
predominantli
gastrointestin
present
identifi
ed
patient
symptomat
within
day
exposur
diseas
poultri
patient
report
poultrybird
exposur
underst
aspect
infl
uenza
earli
nonspecifi
c
febril
present
invit
broad
differenti
diagnosi
dengu
typhoid
fever
flu
includ
swineorigin
infl
uenza
within
fi
rst
day
ill
indonesian
patient
report
fever
cough
rhinorrhea
report
dyspnea
hospit
admiss
report
cough
dyspnea
respect
symptom
characterist
communityacquir
pneumonia
onset
dyspnea
appear
prompt
referr
higher
level
care
diagnosi
manag
technic
natur
ie
polymeras
chain
reaction
pcr
laboratori
diagnosi
infl
uenza
particularli
vast
countri
like
indonesia
limit
access
pcr
diagnosi
sever
ill
known
expos
diagnost
diffi
culti
earli
primari
care
later
stage
hospit
diseas
coupl
low
index
suspicion
lead
diagnost
antivir
treatment
delay
certainli
rapid
progress
respiratori
failur
necessit
earli
ventil
alert
clinician
possibl
infl
uenza
infect
calli
patient
diagnos
pneumonia
patient
mild
fl
ulik
ill
patient
complain
fever
complain
dyspnea
product
cough
symptom
sore
throat
n
myalgia
vomit
diarrhea
headach
drowsi
runni
nose
abdomin
pain
dri
cough
spontan
mucos
bleed
one
report
sore
red
eye
sixteen
patient
leukopenia
l
absolut
lymphopenia
l
neutropenia
l
thrombocytopen
l
includ
sever
l
thrombocytopenia
tabl
sofa
score
tabl
rang
median
respiratori
compon
median
higher
median
sofa
score
associ
death
vs
p
consolid
common
cxr
shadow
seen
ill
present
seven
patient
unilater
bilater
consolid
respect
six
complet
abl
date
contact
median
incub
period
day
patient
previous
well
none
known
diabet
estim
preval
diabet
mellitu
indonesia
million
popul
count
fi
rst
day
report
ill
day
median
durat
ill
fi
rst
medic
contact
day
rang
local
clinic
n
patient
hospit
n
number
medic
contact
persahabatan
hospit
admiss
n
patient
n
n
n
referr
hospit
patient
prescrib
antibiot
also
receiv
oseltamivir
two
famili
cluster
mother
son
mother
daughter
surviv
except
mother
son
son
becam
ill
mother
prescrib
oral
oseltamivir
immedi
present
gener
practition
day
ill
took
two
dose
improv
refer
hospit
earliest
referr
present
persahabatan
hospit
rang
day
median
ill
time
fi
rst
dose
oseltamivir
similar
median
rang
patient
receiv
oseltamivir
either
hospit
day
transfer
refer
hospit
follow
consult
team
three
sever
ill
patient
die
respiratori
failur
soon
admiss
without
receiv
oseltamivir
clini
lobe
consolid
chest
ct
scan
taken
day
later
show
extens
diseas
fig
repeat
ct
scan
day
later
fig
patient
clinic
much
improv
show
partial
resolut
consolid
dilat
bronchi
four
patient
develop
pneumothorac
one
bilater
one
pneumomediastinum
ventil
treat
chest
drainag
whiteout
one
side
without
tracheal
deviat
patient
followup
cxr
develop
worsen
shadow
sometim
within
day
total
patient
featur
consist
pleural
effus
thorac
ultrasound
done
confi
rmation
one
patient
normal
cxr
one
four
survivor
anoth
survivor
right
middl
respiratori
score
platelet
count
creatinin
score
gc
score
mean
ap
score
bilirubin
score
die
nd
score
assum
ap
arteri
pressur
gc
glasgow
coma
score
n
nd
data
ye
see
tabl
expans
abbrevi
two
nine
patient
sputumposit
sampl
streptococcu
pneumonia
pseudomona
aeruginosa
one
survivor
suspect
ventilatorassoci
pneumonia
three
posit
endotrach
aspir
klebsiella
terrigan
pseudomona
cepacia
acinetobact
baumannii
blood
cultur
posit
coagulaseneg
staphylococcu
coagulaseposit
staphylococcu
assum
staphylococcu
aureu
hemolyt
streptococcu
three
patient
die
within
hour
admiss
one
transfer
alreadi
ventil
rest
treat
either
standard
doubl
dose
mg
bid
adult
oseltamivir
antibiot
third
fourth
gener
cephalosporin
azithromycin
levogatifl
oxacin
carbapenem
aminoglycosid
given
cover
communityand
hospitalacquir
bacteri
pneumonia
one
patient
receiv
methylprednisolon
one
dose
mg
iv
given
stop
hematemesi
eleven
patient
receiv
mgkg
daili
ivig
gammagard
baxter
westlak
villag
ca
day
three
surviv
admiss
median
pa
f
io
ratio
rang
interquartil
rang
tabl
three
patient
ali
ard
two
patient
surviv
nineteen
within
h
pleural
fl
uid
obtain
eight
patient
thoracentesi
nine
tap
pleural
fl
uid
sampl
exud
tabl
none
sent
routin
bacteri
cultur
total
differenti
white
cell
count
vari
wide
three
patient
lymphocytepredomin
fl
uid
relationship
blood
pleural
fl
uid
total
white
cell
count
p
spearman
r
pleural
blood
sampl
taken
day
alway
simultan
make
fl
uid
blood
glucos
ratio
unreli
shown
twothird
patient
hyperglycemia
diagnost
rang
impair
glucos
toler
diabet
mellitu
treat
insulin
none
patient
corticosteroid
known
diabet
hyperglycemia
admiss
develop
treatment
steroid
observ
previous
infl
uenza
identifi
ed
possibl
poor
prognost
factor
contrast
hyperglycemia
independ
risk
factor
increas
mortal
patient
sever
acut
respiratori
syndrom
whether
diabet
suboptim
glucos
control
associ
poor
prognosi
critic
ill
patient
often
associ
bacteri
sepsi
import
parallel
may
exist
sepsi
infl
uenza
suggest
fi
nding
limit
number
patient
emphas
need
research
evid
mild
consumpt
coagulopathi
fi
patient
consist
chines
seri
also
use
soft
defi
nition
familiar
clinician
none
patient
met
robust
defi
nition
overt
dic
oner
et
al
seri
two
eight
patient
isth
dic
score
admiss
develop
later
publish
data
suggest
overt
dic
affect
minor
patient
infl
uenza
present
usual
caus
spontan
bleed
ddimer
level
patient
elev
proport
pt
aptt
concentr
fi
brinogen
acutephas
protein
mostli
low
normal
despit
intens
infl
ammat
hallmark
sever
infl
uenza
evidenc
increas
ferritin
crp
level
patient
acutephas
protein
measur
high
ddimer
level
low
fi
brinogen
level
suggest
infl
uenza
associ
fi
brinolysi
absenc
dic
howev
exclud
possibl
clinic
inappar
venou
thromboembol
diseas
patient
report
patient
patient
requir
mechan
ventil
within
day
admiss
tidal
volum
set
mlkg
patient
requir
posit
endexpiratori
pressur
cm
water
one
surviv
patient
develop
clinic
suspect
ventilatorassoci
pneumonia
patient
n
blood
glucos
mgdl
start
iv
insulin
two
patient
diarrhea
part
present
ill
posit
infl
uenza
viru
rectal
swab
patient
convuls
patient
n
die
day
ill
onset
three
die
within
hour
admiss
other
day
death
due
ard
hypotens
necessit
inotrop
support
also
contribut
four
patient
surviv
one
afebril
admiss
mild
diseas
three
other
requir
ventil
day
time
fever
clearanc
rang
day
virus
n
serial
throat
swab
taken
clear
second
fourth
day
admiss
time
viral
clearanc
n
h
n
univari
analys
variabl
associ
signifi
cantli
p
death
owe
small
number
patient
multivari
analysi
done
high
death
rate
patient
human
infl
uenza
tertiari
referr
hospit
jakarta
accord
experi
elsewher
indonesia
present
measur
poor
respiratori
function
predict
death
identifi
ed
hyperglycemia
elev
ddimer
level
elev
urea
level
possibl
poor
prognost
featur
pleural
blood
biochem
result
obtain
sever
hour
apart
therefor
pleuralserum
ratio
interpret
light
l
lymphocyt
ldh
lactat
dehydrogenas
p
polymorph
see
tabl
legend
expans
abbrevi
infl
uenza
posit
calli
ill
patient
admiss
sofa
score
may
also
help
identifi
atrisk
patient
develop
western
patient
sepsi
often
comorbid
multiorgan
failur
shock
whether
sofa
pneumonia
score
system
predominantli
respiratori
ill
relev
requir
research
focus
affect
popul
four
patient
surviv
one
mild
clinic
diseas
normal
cxr
throat
swab
viral
clearanc
confi
rmed
three
patient
within
day
suggest
suffici
oseltamivir
absorpt
antivir
effi
caci
contrast
other
found
continu
infl
uenza
replic
despit
oseltamivir
treatment
associ
death
effi
caci
ivig
unknown
may
contribut
surviv
three
patient
china
convalesc
serum
administ
sever
infl
uenza
patient
also
appear
benefi
cial
combin
immunomodulatori
antivir
drug
therapi
warrant
research
primari
limit
studi
small
number
patient
thu
restrict
statist
power
discern
subtl
effect
also
use
somewhat
crude
classifi
cation
cxr
fi
nding
simpli
classifi
degre
consolid
whether
consolid
unilater
bilater
system
may
help
busi
clinician
lack
fi
ness
classifi
cation
patient
sampl
daili
viru
detect
attempt
made
collect
specimen
measur
oseltamivir
concentr
summari
identifi
ed
new
clinic
featur
infect
infl
uenza
link
poor
outcom
small
seri
patient
confi
rmed
larger
seri
may
shed
new
light
clinic
consequ
human
infl
uenza
infect
author
contribut
dr
soepandi
contribut
clinic
care
laboratori
support
data
collect
read
approv
fi
nal
manuscript
dr
burhan
contribut
clinic
care
laboratori
support
data
collect
manag
statist
analysi
write
fi
rst
draft
manuscript
read
approv
fi
nal
manuscript
dr
mangunnegoro
contribut
clinic
care
laboratori
support
data
collect
read
approv
fi
nal
manuscript
dr
nawa
contribut
clinic
care
laboratori
support
data
collect
read
approv
fi
nal
manuscript
dr
aditama
contribut
clinic
care
laboratori
support
data
collect
read
approv
fi
nal
manuscript
dr
partakusuma
contribut
clinic
care
laboratori
support
data
collect
read
approv
fi
nal
manuscript
dr
isbaniah
contribut
data
manag
write
fi
rst
draft
manuscript
read
approv
fi
nal
manuscript
dr
ikhsan
contribut
clinic
care
laboratori
support
data
collect
read
approv
fi
nal
manuscript
sever
acut
respiratori
syndrom
clinician
awar
ivig
increas
plasma
viscos
predispos
arteri
venou
thromboembol
diseas
result
elev
ddimer
level
elev
urea
level
anoth
possibl
poor
prognost
factor
refl
ect
combin
hypercatabol
dehydr
renal
impair
eight
patient
pleural
effus
confi
rmed
thoracentesi
consist
radiolog
data
southern
vietnam
fi
rst
data
confi
rming
infl
uenza
caus
exud
pleural
effus
fluid
valu
similar
bloodstain
strawcolor
pleural
fl
uid
suggest
necrot
hemorrhag
pneumonia
traumat
tap
ldh
valu
high
consist
sever
lung
parenchym
damag
total
differenti
white
cell
count
vari
diffi
cult
interpret
absenc
histopatholog
bacteriolog
data
patient
present
late
respiratori
failur
featur
ard
ard
common
infl
uenza
affect
minor
patient
pandem
infl
uenza
probabl
refl
ect
propens
infl
uenza
bind
sialic
acid
receptor
lower
respiratori
tract
high
proport
develop
pneumothorac
despit
use
low
tidal
volum
ventil
pneumothorac
also
occur
independ
ventil
underli
eas
pneumothorac
develop
infl
uenza
infect
mechan
incomplet
understood
may
relat
underli
destruct
lung
architectur
pneumatocel
pseudocav
format
effect
mechan
ventil
optim
ventil
set
infl
uenza
current
unknown
need
research
durat
onset
ill
administr
oseltamivir
describ
signific
risk
factor
fatal
outcom
patient
present
soon
ill
onset
treatment
delay
part
relat
unavail
reliabl
infl
uenza
diagnost
tertiari
care
level
low
index
suspicion
face
nondescript
febril
ill
contrast
appar
surviv
infl
uenza
among
patient
diagnos
earli
incid
exposur
known
human
case
testifi
es
import
earli
diagnosi
treatment
fi
nding
affi
rm
urgent
need
simpl
afford
effect
pointofcar
diagnost
infect
identifi
ed
mani
factor
associ
death
number
small
test
independ
howev
clinician
awar
may
clinic
import
seem
prudent
ensur
optim
control
hyperglycemia
even
though
defi
ning
problemat
criti
